|
WO2015024876A2
(en)
|
2013-08-19 |
2015-02-26 |
F. Hoffmann-La Roche Ag |
Screening method
|
|
GB201410693D0
(en)
|
2014-06-16 |
2014-07-30 |
Univ Southampton |
Splicing modulation
|
|
AU2015327836B2
(en)
|
2014-10-03 |
2021-07-01 |
Cold Spring Harbor Laboratory |
Targeted augmentation of nuclear gene output
|
|
EP4249472A3
(en)
|
2015-05-30 |
2023-12-13 |
PTC Therapeutics, Inc. |
Methods for modulating rna splicing
|
|
CN108603230A
(zh)
|
2015-10-09 |
2018-09-28 |
南安普敦大学 |
基因表达的调节与蛋白质表达失调的筛选
|
|
IL294124B2
(en)
|
2015-12-10 |
2024-02-01 |
Ptc Therapeutics Inc |
Methods for treating huntington's disease
|
|
US11096956B2
(en)
|
2015-12-14 |
2021-08-24 |
Stoke Therapeutics, Inc. |
Antisense oligomers and uses thereof
|
|
WO2017106377A1
(en)
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndrome
|
|
EA201991309A1
(ru)
|
2016-11-28 |
2019-11-29 |
|
Способы модуляции сплайсинга рнк
|
|
US11407753B2
(en)
|
2017-06-05 |
2022-08-09 |
Ptc Therapeutics, Inc. |
Compounds for treating Huntington's disease
|
|
KR20200017476A
(ko)
|
2017-06-14 |
2020-02-18 |
피티씨 테라퓨틱스, 인크. |
Rna 스플라이싱의 변경 방법
|
|
WO2019005993A1
(en)
|
2017-06-28 |
2019-01-03 |
Ptc Therapeutics, Inc. |
METHODS OF TREATING HUNTINGTON'S DISEASE
|
|
US11382918B2
(en)
|
2017-06-28 |
2022-07-12 |
Ptc Therapeutics, Inc. |
Methods for treating Huntington's Disease
|
|
WO2019028440A1
(en)
|
2017-08-04 |
2019-02-07 |
Skyhawk Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
|
|
KR102318434B1
(ko)
|
2017-08-25 |
2021-11-01 |
스톡 테라퓨틱스, 인크. |
병태 및 질환 치료용 안티센스 올리고머
|
|
HUE070436T2
(hu)
|
2017-10-23 |
2025-06-28 |
Stoke Therapeutics Inc |
Antiszensz oligomerek nonszensz-mediált RNS-lebomláson alapuló állapotok és betegségek kezelésére
|
|
WO2019126731A1
(en)
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
MX2020009957A
(es)
|
2018-03-27 |
2021-01-15 |
Ptc Therapeutics Inc |
Compuestos para el tratamiento de enfermedad de hungtinton.
|
|
CN112272666A
(zh)
*
|
2018-04-10 |
2021-01-26 |
斯基霍克疗法公司 |
用于治疗癌症的化合物
|
|
CA3099280A1
(en)
|
2018-05-04 |
2019-11-07 |
Stoke Therapeutics, Inc. |
Methods and compositions for treatment of cholesteryl ester storage disease
|
|
PL3814357T3
(pl)
|
2018-06-27 |
2024-09-16 |
Ptc Therapeutics, Inc. |
Związki heterocykliczne i heteroarylowe do leczenia choroby huntingtona
|
|
EP3814345B8
(en)
|
2018-06-27 |
2024-10-30 |
PTC Therapeutics, Inc. |
Heteroaryl compounds for treating huntington's disease
|
|
WO2020163248A1
(en)
|
2019-02-04 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
JP2022519294A
(ja)
*
|
2019-02-04 |
2022-03-22 |
スカイホーク・セラピューティクス・インコーポレーテッド |
スプライシングを調節するための方法および組成物
|
|
CN113692402A
(zh)
*
|
2019-02-04 |
2021-11-23 |
斯基霍克疗法公司 |
用于调节剪接的方法和组合物
|
|
EP3920915A4
(en)
|
2019-02-05 |
2022-10-05 |
Skyhawk Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODULATING SPLICE
|
|
KR20210134657A
(ko)
*
|
2019-02-05 |
2021-11-10 |
스카이호크 테라퓨틱스, 인코포레이티드 |
스플라이싱을 조절하는 방법 및 조성물
|
|
CN114126613A
(zh)
*
|
2019-02-05 |
2022-03-01 |
斯基霍克疗法公司 |
用于调节剪接的方法和组合物
|
|
CN113677342A
(zh)
*
|
2019-02-05 |
2021-11-19 |
斯基霍克疗法公司 |
用于调节剪接的方法和组合物
|
|
WO2020163544A1
(en)
|
2019-02-06 |
2020-08-13 |
Skyhawk Therapeutics, Inc. |
Methods and compositions for modulating splicing
|
|
CN113661162A
(zh)
|
2019-02-06 |
2021-11-16 |
斯基霍克疗法公司 |
用于调节剪接的方法和组合物
|
|
AU2020227825B2
(en)
|
2019-02-27 |
2026-03-26 |
Stoke Therapeutics, Inc. |
Antisense oligomers for treatment of conditions and diseases
|
|
WO2020231977A1
(en)
|
2019-05-13 |
2020-11-19 |
Ptc Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
AR119731A1
(es)
|
2019-05-17 |
2022-01-05 |
Novartis Ag |
Inhibidores del inflamasoma nlrp3
|
|
US11129829B2
(en)
|
2019-06-17 |
2021-09-28 |
Skyhawk Therapeutics, Inc. |
Methods for modulating splicing
|
|
TW202112767A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
|
|
WO2021174167A1
(en)
|
2020-02-28 |
2021-09-02 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
CA3169697A1
(en)
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Thiophenyl derivatives useful for modulating nucleic acid splicing
|
|
JP7736700B2
(ja)
|
2020-02-28 |
2025-09-09 |
リミックス セラピューティクス インコーポレイテッド |
複素環アミド及びスプライシングを調節するためのその使用
|
|
MX2022010634A
(es)
|
2020-02-28 |
2023-01-19 |
Remix Therapeutics Inc |
Derivados de piridazina para modular el empalme de acidos nucleicos.
|
|
KR20230005210A
(ko)
|
2020-04-08 |
2023-01-09 |
레믹스 테라퓨틱스 인크. |
스플라이싱을 조절하기 위한 화합물 및 방법
|
|
JP2023520916A
(ja)
|
2020-04-08 |
2023-05-22 |
リミックス セラピューティクス インコーポレイテッド |
スプライシングを調整するための化合物及び方法
|
|
CN115867657A
(zh)
|
2020-05-11 |
2023-03-28 |
斯托克制药公司 |
用于治疗疾患和疾病的opa1反义寡聚物
|
|
EP4175956A1
(en)
|
2020-07-02 |
2023-05-10 |
Remix Therapeutics Inc. |
2-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
EP4178963A1
(en)
|
2020-07-02 |
2023-05-17 |
Remix Therapeutics Inc. |
5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
CN112716946B
(zh)
*
|
2021-01-22 |
2022-02-08 |
中国人民解放军陆军军医大学 |
磺内酰胺-环己酮螺环衍生物1-3-51在制备治疗胃癌药物中的应用
|
|
WO2023034836A1
(en)
|
2021-08-30 |
2023-03-09 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20240400584A1
(en)
|
2021-08-30 |
2024-12-05 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
WO2023034812A1
(en)
|
2021-08-30 |
2023-03-09 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
IL311132A
(en)
|
2021-08-30 |
2024-04-01 |
Remix Therapeutics Inc |
Splicing Modulation Compounds and Methods
|
|
US20240368163A1
(en)
|
2021-08-30 |
2024-11-07 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
CA3233973A1
(en)
|
2021-10-13 |
2023-04-20 |
Dominic Reynolds |
Compounds and methods for modulating nucleic acid splicing
|
|
WO2023064879A1
(en)
|
2021-10-13 |
2023-04-20 |
Remix Therapeutics Inc. |
Compounds and methods for modulating nucleic acid splicing
|
|
US20250326748A1
(en)
|
2022-01-05 |
2025-10-23 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20250109140A1
(en)
|
2022-01-05 |
2025-04-03 |
Remix Theraputics Inc. |
5-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
WO2023133217A1
(en)
|
2022-01-05 |
2023-07-13 |
Remix Therapeutics Inc. |
2-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseases
|
|
UY40374A
(es)
|
2022-08-03 |
2024-02-15 |
Novartis Ag |
Inhibidores de inflamasoma nlrp3
|
|
WO2025247338A1
(zh)
*
|
2024-05-30 |
2025-12-04 |
纽欧申医药(上海)有限公司 |
哒嗪环类化合物、其药物组合物及其应用
|